News About: Goverment
Elderly patient's own payment necessarily to improve.
Seoul Pharmaceutical Association, Medical and Pharmacy Practice Separation Committee discussed in the representative's meeting of each district association medical/pharmacy practice separation committee on Oct. 14 how...
NHI reimbursement to grant for 103 new products.
The MOHW announced on Oct. 17 that the NHI reimbursement coverage would be extended to 103 new products including 12 orphan drugs for the treatment of multisclerosis and other incurable diseases, for which about 16 bi...
Drug Information Center to operate in 1/2 of 2006.
The Korea Drug Information Center, an agency responsible to collect, administer, analyse, assess and provide various drug informations, may start its operation probably from the 2nd half of 2006 as Rep. Kang Ki-jeong ...
KFDA to review 911 drugs including 61 GSK products.
The KFDA reported in "The status of new drugs and others to review" that the total 911 drugs should be reviewed, of which GSK had the highest number of products including Avandia, an anti-diabetic drug, among the fore...
Graded NHI payable for time job pharmacists from Nov.
A graded NHI payment for the services rendered by a time employed pharmacist may take effect from November according to the MOHW.
The MOHW announced to ameliorate 53 items including the subjects on the reinforcemen...
Illegal bulk drugs imported and sold.
Rep. Koh Kyeong-wha of the GNP said by quoting the KFDA data that in 2005 a local company imported illegal bulk drugs from Japan as much as 64 million won and in unit of 2ml ampules x 160,000 and another company impor...
Deleterious herbal drugs not to classify as prescription drugs.
In responding to the inquiry raised by Rep. Kang Ki-jeong of National Assembly about which deleterious herbal drugs such as Ephedra herba and Aconiti tuber should be classified as a prescription drug, the KFDA said it...
Prescription collusion on the rise.
A medical practice collusion between doctors and pharmacists in an informally written prescription sheet is widely prevalent, which seriously hampers the medical reform program.
According to a joint survey against ...
KFDA to adopt poor quality drug recall system
A drug of the registration cancellation or the unacceptable qualities will be far more strictly controlled via a recall and scrap under the legal and systematic process.
Chief KFDA commissioner Kim Jeong-sook sai...
Government R&D subsidy for new drugs wasteful.
Rep. Hyun Ae-jo disclosed the Korea Health Industry Development Institute(KHIDI) report covering that only 8 subjects of the new drug R&D financially supported by the government up to April 2005 had been successfully ...
